Brandon Phan
Nurse Practitioner · Los Gatos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 2 carriers
- Office
- 1
Offices
1 location · Thinh Duy Mai MD Apc · 6 clinicians in this group
Plans that list them
3 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Brandon Phan’s office at (408) 363-6533 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
3 of 3 plans
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
Drugs they prescribed that Part D paid
$20,345
Pharmacies billed $20,345 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 260) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
253 generic and fewer than 11 brand-name prescriptions · $20,345 in drug cost · 14 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Olanzapine | 20 | $829 | $41 |
| Divalproex Sodium Er | 17 | $594 | $35 |
| Risperidone | 18 | $378 | $21 |
| Quetiapine | 12 | $313 | $26 |
| Gabapentin | 22 | $287 | $13 |
See all 10 drugs
| Olanzapine | 20 | $829 | $41 |
| Divalproex Sodium Er | 17 | $594 | $35 |
| Risperidone | 18 | $378 | $21 |
| Quetiapine | 12 | $313 | $26 |
| Gabapentin | 22 | $287 | $13 |
| Fluoxetine | 13 | $286 | $22 |
| Benztropine Mesylate | 18 | $211 | $12 |
| Clonazepam | 37 | $200 | $5 |
| Lamotrigine | 11 | $16 | $1 |
| Sertraline | 21 | $6 | $0 |
Money from drug and device companies
$3,852 in 2025
| 2025 | 16 | 131 | None | $3,852 |
| 2024 | 22 | 107 | None | $3,425 |
| 2023 | 2 | 2 | None | $156 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Neurocrine BioSciences | Ingrezza | $578 | 14 payments
|
| Abbvie | Vraylar | $514 | 29 payments
|
| Teva Pharmaceuticals USA | Austedo Xr | $408 | 10 payments
|
| Otsuka America Pharmaceutical | Rexulti | $363 | 12 payments
|
| Vanda Pharmaceuticals | Fanapt | $337 | 13 payments
|
| Axsome Therapeutics | Auvelity | $305 | 8 payments
|
See all 131 published payments
| Abbvie | Meals · 2025-12-23 | Vraylar | $4 |
| Alkermes | Meals · 2025-12-23 | Aristada | $30 |
| Otsuka Pharmaceutical Development & Commercialization | Meals · 2025-12-18 | Rexulti | $26 |
| Abbvie | Meals · 2025-12-17 | Vraylar | $6 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-12-16 | Cobenfy | $29 |
| Otsuka America Pharmaceutical | Meals · 2025-12-16 | Rexulti | $2 |
| Otsuka America Pharmaceutical | Meals · 2025-12-10 | Rexulti | $26 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-12-04 | Caplyta | $30 |
| Teva Pharmaceuticals USA | Meals · 2025-12-04 | Austedo Xr | $29 |
| Otsuka America Pharmaceutical | Meals · 2025-12-02 | Rexulti | $27 |
| Neurocrine BioSciences | Meals · 2025-11-20 | Ingrezza | $30 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-11-19 | Cobenfy | $14 |
| Otsuka America Pharmaceutical | Meals · 2025-11-19 | Rexulti | $29 |
| Axsome Therapeutics | Meals · 2025-11-19 | Auvelity | $27 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-11-12 | Caplyta | $31 |
| Abbvie | Meals · 2025-11-04 | Vraylar | $19 |
| Abbvie | Meals · 2025-10-22 | Vraylar | $23 |
| Tris Pharma | Meals · 2025-10-16 | Dyanavel Xr | $27 |
| Abbvie | Meals · 2025-10-16 | Vraylar | $22 |
| Teva Pharmaceuticals USA | Meals · 2025-10-09 | Austedo Xr | $21 |
| Alkermes | Meals · 2025-10-08 | Aristada | $34 |
| Otsuka America Pharmaceutical | Meals · 2025-10-08 | Rexulti | $125 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-10-08 | Caplyta | $23 |
| Abbvie | Meals · 2025-10-07 | Vraylar | $9 |
| Neurocrine BioSciences | Meals · 2025-10-03 | Ingrezza | $30 |
| Lundbeck | Meals · 2025-10-01 | Rexulti | $27 |
| Alkermes | Meals · 2025-09-26 | Aristada | $25 |
| Vanda Pharmaceuticals | Meals · 2025-09-25 | Fanapt | $19 |
| Vanda Pharmaceuticals | Meals · 2025-09-25 | Fanapt | $2 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-09-25 | Caplyta | $35 |
| Abbvie | Meals · 2025-09-24 | Vraylar | $6 |
| Abbvie | Meals · 2025-09-19 | Vraylar | $27 |
| Otsuka America Pharmaceutical | Meals · 2025-09-17 | Rexulti | $14 |
| Collegium Pharmaceutical | Meals · 2025-09-11 | Jornay Pm | $23 |
| Axsome Therapeutics | Meals · 2025-09-11 | Auvelity | $116 |
| Neurocrine BioSciences | Meals · 2025-09-11 | Ingrezza | $35 |
| Teva Pharmaceuticals USA | Meals · 2025-09-11 | Austedo Xr | $13 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-09-09 | Caplyta | $33 |
| Abbvie | Meals · 2025-09-05 | Vraylar | $22 |
| Vanda Pharmaceuticals | Meals · 2025-09-04 | Fanapt | $21 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-09-03 | Trintellix | $25 |
| Teva Pharmaceuticals USA | Meals · 2025-08-28 | Austedo Xr | $118 |
| Abbvie | Meals · 2025-08-27 | Vraylar | $5 |
| Teva Pharmaceuticals USA | Meals · 2025-08-26 | Austedo Xr | $19 |
| Lundbeck | Meals · 2025-08-21 | Rexulti | $28 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-08-20 | Caplyta | $26 |
| Neurocrine BioSciences | Meals · 2025-08-15 | Ingrezza | $5 |
| Abbvie | Meals · 2025-08-14 | Vraylar | $31 |
| Neurocrine BioSciences | Meals · 2025-08-14 | Ingrezza | $29 |
| Vanda Pharmaceuticals | Meals · 2025-08-13 | Fanapt | $29 |
| Otsuka America Pharmaceutical | Meals · 2025-08-12 | Rexulti | $24 |
| Neurocrine BioSciences | Meals · 2025-08-06 | Ingrezza | $24 |
| Otsuka America Pharmaceutical | Meals · 2025-07-31 | Rexulti | $21 |
| Abbvie | Meals · 2025-07-30 | Vraylar | $9 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-07-25 | Caplyta | $34 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-07-23 | Trintellix | $23 |
| Neurocrine BioSciences | Meals · 2025-07-23 | Ingrezza | $23 |
| Vanda Pharmaceuticals | Meals · 2025-07-18 | Fanapt | $23 |
| Vanda Pharmaceuticals | Meals · 2025-07-18 | Fanapt | $3 |
| Abbvie | Meals · 2025-07-17 | Vraylar | $28 |
| Teva Pharmaceuticals USA | Meals · 2025-07-17 | Austedo Xr | $31 |
| Janssen Pharmaceuticals | Meals · 2025-07-15 | Invega Sustenna | $30 |
| Alkermes | Meals · 2025-07-10 | Aristada | $33 |
| Teva Pharmaceuticals USA | Meals · 2025-07-04 | Austedo Xr | $23 |
| Otsuka America Pharmaceutical | Meals · 2025-07-03 | Rexulti | $24 |
| Abbvie | Meals · 2025-07-02 | Vraylar | $6 |
| Teva Pharmaceuticals USA | Education · 2025-07-02 | None | $111 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-07-01 | Caplyta | $32 |
| Almatica Pharma | Meals · 2025-06-25 | Loreev Xr | $18 |
| Lundbeck | Meals · 2025-06-19 | Rexulti | $31 |
| Vanda Pharmaceuticals | Meals · 2025-06-18 | Fanapt | $14 |
| Axsome Therapeutics | Meals · 2025-06-17 | Auvelity | $19 |
| Abbvie | Meals · 2025-06-16 | Vraylar | $8 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-06-04 | Trintellix | $31 |
| Neurocrine BioSciences | Meals · 2025-06-04 | Ingrezza | $32 |
| Abbvie | Meals · 2025-06-03 | Vraylar | $4 |
| Teva Pharmaceuticals USA | Meals · 2025-06-03 | Austedo Xr | $20 |
| Collegium Pharmaceutical | Meals · 2025-05-29 | Jornay Pm | $23 |
| Otsuka America Pharmaceutical | Meals · 2025-05-28 | Rexulti | $23 |
| Abbvie | Meals · 2025-05-22 | Vraylar | $25 |
| Teva Pharmaceuticals USA | Meals · 2025-05-21 | Austedo Xr | $25 |
| Axsome Therapeutics | Meals · 2025-05-20 | Sunosi | $34 |
| Abbvie | Meals · 2025-05-16 | Vraylar | $27 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-05-15 | Trintellix | $28 |
| Lundbeck | Meals · 2025-05-15 | Rexulti | $25 |
| Almatica Pharma | Meals · 2025-05-08 | Loreev Xr | $22 |
| Neurocrine BioSciences | Meals · 2025-05-07 | Ingrezza | $133 |
| Neurocrine BioSciences | Meals · 2025-05-02 | Ingrezza | $34 |
| Lundbeck | Meals · 2025-05-01 | Rexulti | $26 |
| Vanda Pharmaceuticals | Meals · 2025-04-30 | Fanapt | $31 |
| Alkermes | Meals · 2025-04-25 | Aristada | $27 |
| Abbvie | Meals · 2025-04-24 | Vraylar | $28 |
| Vanda Pharmaceuticals | Meals · 2025-04-24 | Fanapt | $124 |
| Axsome Therapeutics | Meals · 2025-04-18 | Auvelity | $27 |
| Otsuka America Pharmaceutical | Meals · 2025-04-16 | Rexulti | $24 |
| Abbvie | Meals · 2025-04-10 | Vraylar | $11 |
| Vanda Pharmaceuticals | Meals · 2025-04-10 | Fanapt | $10 |
| Vanda Pharmaceuticals | Meals · 2025-04-09 | Fanapt | $12 |
| Neurocrine BioSciences | Meals · 2025-04-03 | Ingrezza | $37 |
| Abbvie | Meals · 2025-03-28 | Vraylar | $23 |
| Alkermes | Meals · 2025-03-26 | Aristada | $17 |
| Alkermes | Meals · 2025-03-20 | Aristada | $30 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-03-19 | Cobenfy | $7 |
| Abbvie | Meals · 2025-03-13 | Vraylar | $28 |
| Axsome Therapeutics | Meals · 2025-03-11 | Auvelity | $27 |
| Vanda Pharmaceuticals | Education · 2025-03-10 | Fanapt | $12 |
| Lundbeck | Meals · 2025-03-06 | Rexulti | $26 |
| Axsome Therapeutics | Meals · 2025-03-05 | Auvelity | $23 |
| Abbvie | Meals · 2025-02-28 | Vraylar | $9 |
| Abbvie | Meals · 2025-02-27 | Vraylar | $27 |
| Alkermes | Meals · 2025-02-25 | Aristada | $29 |
| Abbvie | Meals · 2025-02-21 | Vraylar | $27 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-02-19 | Trintellix | $30 |
| Neurocrine BioSciences | Meals · 2025-02-14 | None | $101 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-02-13 | Cobenfy | $115 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-02-11 | Caplyta | $2 |
| Janssen Pharmaceuticals | Meals · 2025-02-07 | Spravato | $17 |
| Neurocrine BioSciences | Meals · 2025-02-06 | Ingrezza | $32 |
| Tris Pharma | Meals · 2025-01-31 | Dyanavel Xr | $22 |
| Lundbeck | Meals · 2025-01-30 | Rexulti | $33 |
| Abbvie | Meals · 2025-01-28 | Vraylar | $18 |
| Vanda Pharmaceuticals | Meals · 2025-01-24 | Fanapt | $38 |
| Abbvie | Meals · 2025-01-18 | Vraylar | $29 |
| Axsome Therapeutics | Meals · 2025-01-17 | Auvelity | $32 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-01-15 | Cobenfy | $125 |
| Abbvie | Meals · 2025-01-15 | Vraylar | $6 |
| Otsuka America Pharmaceutical | Meals · 2025-01-15 | Rexulti | $24 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-01-14 | Caplyta | $24 |
| Neurocrine BioSciences | Meals · 2025-01-09 | Ingrezza | $34 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-01-08 | Trintellix | $20 |
| Abbvie | Meals · 2025-01-03 | Vraylar | $25 |
See earlier years (2024, 2023)
2024: $3,425
| Alkermes | Aristada | $573 | 11 payments
|
| Teva Pharmaceuticals USA | Austedo Xr | $442 | 5 payments
|
| Axsome Therapeutics | Auvelity | $342 | 11 payments
|
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $337 | 5 payments
|
| Abbvie | Vraylar | $321 | 16 payments
|
| Neurocrine Biosciences | Ingrezza | $238 | 11 payments
|
| Lundbeck | Rexulti | $206 | 7 payments
|
| Indivior | Perseris | $190 | 12 payments
|
| Otsuka America Pharmaceutical | Rexulti | $173 | 3 payments
|
| Corium | Azstarys | $142 | 6 payments
|
| Janssen Pharmaceuticals | Invega | $89 | 3 payments
|
| Tris Pharma | Dyanavel Xr | $58 | 3 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $56 | 3 payments
|
| Almatica Pharma | Loreev Xr | $51 | 2 payments
|
| Ironshore Pharmaceuticals | Jornay Pm | $38 | 2 payments
|
| Azurity Pharmaceuticals | None | $33 | 1 payment
|
| Vanda Pharmaceuticals | Fanapt | $27 | 1 payment
|
| Bausch Health US | Aplenzin | $24 | 1 payment
|
| Noven Therapeutics | Xelstrym | $24 | 1 payment
|
| Idorsia Pharmaceuticals US | Quviviq | $23 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Cobenfy | $22 | 1 payment
|
| Biogen | None | $17 | 1 payment
|
2023: $156
| Corium | Azstarys | $133 | 1 payment
|
| Merck Sharp & Dohme | Belsomra | $23 | 1 payment
|
Professional record
- NPI
- 1831979863
- Licence
- CA 95026423
- Group
- Thinh Duy Mai MD Apc
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 363LP0808X (363LP0808X)
- Mailing address
- 61 Victory Ln Ste A, Los Gatos, CA, 95030
- NPI first listed
- 2023-10-05
- NPI last updated
- 2023-10-19
- NPI record certified
- 2023-10-19
This is when the NPI record was last certified, not a medical board exam.